Maryvonne Hiance
Director/Board Member at OSE IMMUNOTHERAPEUTICS
Net worth: 3 M $ as of 2024-04-29
Network origin in Maryvonne Hiance first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 31 | |
Olgram SAS
 Olgram SAS Miscellaneous Commercial ServicesCommercial Services Olgram SAS provides scientific research and development services. The company is based in Brehan, France. The French company was founded by Hervé Balusson, Maryvonne Hiance, Karim Asehnoune, Pi Nyvall Collén, Pierre Rocheteau. Pierre Rocheteau has been the CEO since incorporation.
4
| Holding Company | Miscellaneous Commercial Services | 4 |
France Biotech Association
 France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin.
2
| Non-Profit Organization | Miscellaneous Commercial Services | 2 |
Healthtech For Care
1
| Private Company | 1 | |
Atlanpole Biotherapies
 Atlanpole Biotherapies Miscellaneous Commercial ServicesCommercial Services Atlanpole Biotherapies provides immunotherapy, regenerative medicine, and radio pharmacy bio cluster services. The company is based in Nantes, France.
1
| Holding Company | Miscellaneous Commercial Services | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Maryvonne Hiance via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| SANOFI | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| TENGION, INC. | Biotechnology | Director/Board Member | |
| IPSEN | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| GUERBET | Medical Specialties | Sales & Marketing Comptroller/Controller/Auditor | |
Paul Capital Partners LP
 Paul Capital Partners LP Investment ManagersFinance Founded in 1991 by Philip Paul, Paul Capital Partners LP is a private equity firm located in San Francisco with additional offices in New York City, Hong Kong, London, Paris and São Paulo. | Investment Managers | Private Equity Investor Corporate Officer/Principal | |
| VALERIO THERAPEUTICS | Pharmaceuticals: Major | Chief Executive Officer Founder Chief Tech/Sci/R&D Officer | |
Rhone Poulenc Rorer
 Rhone Poulenc Rorer Chemicals: SpecialtyProcess Industries Part of Solvay SA, Rhone Poulenc Rorer is a French pharmaceutical company that manufactures and distributes pharmaceutical products. | Chemicals: Specialty | Corporate Officer/Principal | |
Seventure Partners SA
 Seventure Partners SA Investment ManagersFinance Seventure Partners SA (Seventure) is a Venture Capital firm, a subsidiary of Natixis SA founded in 1997. Seventure Partners SA is headquartered in Paris. | Investment Managers | Chief Executive Officer Chief Executive Officer | |
| DBV TECHNOLOGIES | Pharmaceuticals: Major | Director/Board Member | |
MSD Vaccines Ltd.
 MSD Vaccines Ltd. Pharmaceuticals: OtherHealth Technology MSD Vaccines Ltd. manufactures and supplies vaccines. Its main way of achieving this goal is to develop and make available innovative vaccines against a wide spectrum of diseases. It also dedicated to increasing the understanding of the value of vaccines and vaccination by providing relevant and accurate information on their quality, safety and efficacy. The company was founded in 1975 and is headquartered in Maidenhead, the United Kingdom. | Pharmaceuticals: Other | Chairman | |
| THERADIAG | Medical Specialties | Director/Board Member Chairman | |
Institut National de la Santé & de la Recherche Médicale
 Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| École des Hautes Études Commerciales de Paris | College/University | Masters Business Admin Undergraduate Degree Masters Business Admin Masters Business Admin Masters Business Admin | |
| ESCP Europe Campus Paris | College/University | Undergraduate Degree | |
Sanofi Pasteur
 Sanofi Pasteur BiotechnologyHealth Technology Sanofi Pasteur SA develops, manufactures and supplies vaccines. It provides vaccines for bacterial and viral diseases, including diphtheria, typhoid fever, and poliomyelitis. The company was founded in 1990 and is headquartered in Lyon, France. | Biotechnology | Chairman | |
| European Vaccine Manufacturers | President | ||
| University of Lyon | College/University | Doctorate Degree Undergraduate Degree | |
Centre National de la Recherche Scientifique
 Centre National de la Recherche Scientifique General GovernmentGovernment Centre National de la Recherche Scientifique provides scientific research services. The firm engages in the research capable of advancing knowledge and bringing social, cultural, and economic benefits for society. The company was founded in 1939 and is headquartered in Paris, France. | General Government | Corporate Officer/Principal Corporate Officer/Principal | |
Mouvement des Entreprises de France
 Mouvement des Entreprises de France Miscellaneous Commercial ServicesCommercial Services Mouvement des Entreprises de France operates a network for entrepreneurs. The non-profit company is based in Paris, France. The CEO of the French company is Philippe Pascal Rene Gautier. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Ipsen Pharma SAS
 Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| SENSORION | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| The University of Chicago Booth School of Business | College/University | Masters Business Admin | |
Germitec SA
 Germitec SA Medical SpecialtiesHealth Technology Germitec SA engages in the research, design, and marketing of medical hygiene systems. It develops Antigermix, which is used in disinfecting heat-sensitive medical instruments. The company was founded in 2005 and is headquartered in Ivry-sur-Seine, France. | Medical Specialties | Director/Board Member | |
| GENSIGHT BIOLOGICS S.A. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| BioVision | Chairman | ||
| Myasterix | Director/Board Member | ||
| Fondation pour l’Université de Lyon | Chairman | ||
| ABIVAX | Pharmaceuticals: Other | Director/Board Member Corporate Officer/Principal | |
Calypso Biotech SA
 Calypso Biotech SA Pharmaceuticals: MajorHealth Technology Calypso Biotech SA operates as a innovative biopharmaceutical company for gastrointestinal immunological disorders. The company was founded by Alain Vicari and Yolande Chvatchko in 2013 and is headquartered in Plan-les-Ouates, Germany. | Pharmaceuticals: Major | Director/Board Member | |
| OSE Pharmaceuticals | Director/Board Member Chief Executive Officer | ||
| Louis Dreyfus Foundation | Director/Board Member | ||
Horama SA
 Horama SA BiotechnologyHealth Technology Horama SA engages in the development of gene therapies, It focuses on ophthalmological diseases for preserving visual autonomy of patients. The company was founded by Denis Cayet, Christian Hamel, Guylene Le Meur, Philippe Moullier, Vasiliki Kalatzis, and Michel Weberin March 2014 and is headquartered in Paris, France. | Biotechnology | Director/Board Member Director/Board Member | |
| Aventis Pharma International SAS | Corporate Officer/Principal | ||
Ipsen Bioscience, Inc.
 Ipsen Bioscience, Inc. BiotechnologyHealth Technology Part of Ipsen SA, Ipsen Bioscience, Inc. is a company that develops and wholesales drugs. The company is based in Cambridge, MA. | Biotechnology | Chairman | |
Ipsen (Beijing) Pharmaceutical Science & Technology Dev
 Ipsen (Beijing) Pharmaceutical Science & Technology Dev Miscellaneous Commercial ServicesCommercial Services Part of Ipsen SA, Ipsen (Beijing) Pharmaceutical Science & Technology Dev develops pharmaceutical sciences and technologies. The company is based in Beijing, China. | Miscellaneous Commercial Services | Director/Board Member | |
| Underground Charity Foundation | Chairman | ||
| Fondation Universite Grenoble Alpes | Director/Board Member | ||
| Goliver Therapeutics | Director/Board Member | ||
Big Booster'S
 Big Booster'S Miscellaneous Commercial ServicesCommercial Services Big Booster's is an international accelerator that focuses on positive impact. The French company has accelerated 278 startups to date. The private company was founded by Didier Hoch and has four years of experience in accelerating startups. | Miscellaneous Commercial Services | Founder | |
Dendrogenix SA
 Dendrogenix SA Pharmaceuticals: MajorHealth Technology Dendrogenix SA is a Belgian Belgium-based biotech company founded in 2018 that designs, develops, and brings proprietary molecules called dendrogenins to patients in the fields of hearing loss and neurology. The company is based in Liege, Belgium. Dendrogenins are cholesterol derivatives that stimulate cell differentiation in the immune and nervous system and induce growth of dendrites on dendritic cell and neuron precursors. The company has developed strong know-how in the chemical and biological aspects of dendrogenins. The company was founded by Stéphane Silvente, Gérard Tobelem, and Philippe Lefèbvre, with Stéphane Silvente serving as CEO since 2018. | Pharmaceuticals: Major | Chairman Founder | |
| PHAXIAM THERAPEUTICS S.A. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Ms Medical Synergy SA
 Ms Medical Synergy SA Pharmaceuticals: MajorHealth Technology Ms Medical Synergy SA develops pharmaceutical products. It provides materials and products for the medical industry. The firm also offers seminars for the pharmaceutical area. The company was founded on February 3, 1986 and is headquartered in Geneva, Switzerland. | Pharmaceuticals: Major | Founder Director/Board Member |
Statistics
International
| France | 36 |
| United States | 6 |
| Belgium | 5 |
| Switzerland | 4 |
| United Kingdom | 2 |
Sectoral
| Health Technology | 28 |
| Consumer Services | 6 |
| Commercial Services | 5 |
| Finance | 3 |
| Process Industries | 2 |
Operational
| Director/Board Member | 137 |
| Corporate Officer/Principal | 70 |
| Chief Executive Officer | 49 |
| Independent Dir/Board Member | 37 |
| Chairman | 35 |
Most connected contacts
| Insiders | |
|---|---|
| Eric Jean Marie Leire | 27 |
| Walter Flamenbaum | 26 |
| Didier Hoch | 24 |
| Franck Grimaud | 22 |
| Alexandre LeBeaut | 22 |
| David de Weese | 15 |
| Dominique Costantini | 15 |
| Diane Jorkasky | 15 |
| Elsy Boglioli Hofman | 14 |
| Cédric Moreau | 14 |
| Guy Chatelain | 13 |
| Alexis Peyroles | 10 |
| Emile Loria | 10 |
| Jean-Patrick Demonsang | 9 |
| Gérard Tobelem | 9 |
- Stock Market
- Insiders
- Maryvonne Hiance
- Company connections
